Internal Medicine, Infectious Disease · Mobile, AL
NPI
1821002205
Since 2006
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
1
Medicare group memberships
Hospitals
6
Hospital affiliations
101 Memorial Hospital Dr Ste 200
Mobile, AL, 36608
Phone (251) 414-5900
Groups this clinician bills Medicare through
Medicare paid, 2024
$140K
3,090 services
Medicare patients, 2024
496
Average age 73
Drug cost, 2024
$2.8M
4,047 prescriptions
Company payments, 2025
$961
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Patrick E Nolan was code 99232 (hospital e&m - subsequent), 787 times for 264 patients. In total Patrick E Nolan billed 3,090 services in 67 codes, and Medicare paid $140K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-05-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 787 | 264 | $57.32 | $45K |
| 99214 Office E&M - Established | Office | 262 | 123 | $84.53 | $22K |
| 99233 Hospital E&M - Subsequent | Facility | 252 | 126 | $84.51 | $21K |
| 99223 Hospital E&M - Initial | Facility | 225 | 208 | $124.97 | $28K |
| 36415 Venipuncture Blood Collection | Office | 145 | 77 | $5.88 | $853 |
| 85025 Blood Count | Office | 131 | 65 | $7.61 | $996 |
| 80053 Clinical Chemistry | Office | 103 | 60 | $10.29 | $1,060 |
| 85652 Clinical Chemistry | Office | 57 | 21 | $2.61 | $149 |
| 86140 Clinical Chemistry | Office | 46 | 18 | $5.08 | $234 |
| 83735 Clinical Chemistry | Office | 39 | 29 | $6.57 | $256 |
| 80061 Clinical Chemistry | Office | 35 | 24 | $12.96 | $453 |
| 80048 Clinical Chemistry | Office | 34 | 18 | $7.90 | $269 |
| 84443 Clinical Chemistry | Office | 22 | 18 | $16.46 | $362 |
| 82550 Clinical Chemistry | Office | 21 | 17 | $6.38 | $134 |
| 84439 Clinical Chemistry | Office | 19 | 17 | $8.84 | $168 |
By year: 2022 $172K for 4,416 services; 2023 $162K for 26,114 services; 2024 $140K for 3,090 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 145 | 77 | $5.88 | $853 |
| 85025 Blood Count | 131 | 65 | $7.61 | $996 |
| 80053 Clinical Chemistry | 103 | 60 | $10.29 | $1,060 |
| 85652 Clinical Chemistry | 57 | 21 | $2.61 | $149 |
| 86140 Clinical Chemistry | 46 | 18 | $5.08 | $234 |
| 83735 Clinical Chemistry | 39 | 29 | $6.57 | $256 |
| 80061 Clinical Chemistry | 35 | 24 | $12.96 | $453 |
| 80048 Clinical Chemistry | 34 | 18 | $7.90 | $269 |
| 84443 Clinical Chemistry | 22 | 18 | $16.46 | $362 |
| 82550 Clinical Chemistry | 21 | 17 | $6.38 | $134 |
Medicare prescription drug claims, 2024
In 2024, the drug Patrick E Nolan prescribed most often to Medicare patients was Daptomycin, with 298 prescriptions and refills. In total Patrick E Nolan wrote 4,047 Medicare prescriptions that cost $2.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Daptomycin Generic | 298 | 298 | 51 | $150K |
| Vancomycin Hcl Generic | 280 | 280 | 54 | $41K |
| Cefepime Hcl Generic | 231 | 231 | 53 | $27K |
| Ceftriaxone Ceftriaxone Sodium | 211 | 211 | 40 | $11K |
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 166 | 173 | 17 | $719K |
| Sodium Chloride 0.9 % Sodium Chloride | 141 | 141 | 29 | $1,019 |
| Doxycycline Hyclate Generic | 133 | 160 | 42 | $3,796 |
| Cephalexin Generic | 126 | 164 | 36 | $4,830 |
| Piperacillin-Tazobactam Piperacillin Sodium/Tazobactam | 96 | 96 | 14 | $15K |
| Ertapenem Ertapenem Sodium | 83 | 83 | 21 | $31K |
| Azithromycin Generic | 81 | 110 | 25 | $5,706 |
| Ethambutol Hcl Generic | 66 | 80 | 13 | $4,242 |
| Triumeq Abacavir/Dolutegravir/Lamivudi | 62 | 68 | Under 11 | $263K |
| Dovato Dolutegravir Sodium/Lamivudine | 60 | 64 | Under 11 | $187K |
| Levothyroxine Sodium Generic | 59 | 123 | 12 | $723 |
Brand drugs: 942 claims; generic drugs: 3,105 claims; opioid claims: 24.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Patrick E Nolan $961 ($961 in general payments such as food, travel and fees) from 10 companies. The largest payer was ViiV Healthcare Company with $407.
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company GSK | 20 | $407 |
| Merck Sharp & Dohme LLC MRK | 8 | $173 |
| Gilead Sciences, Inc. GILD | 4 | $85.68 |
| Theratechnologies Inc. THTX | 2 | $74.33 |
| Shionogi Inc 4507.T | 2 | $51.77 |
| Melinta Therapeutics, LLC | 2 | $46.52 |
| Abbvie Inc. ABBV | 2 | $41.59 |
| Seqirus USA Inc CSL.AX | 1 | $33.74 |
| Pfizer Inc. PFE | 1 | $31.07 |
| Ferring Pharmaceuticals Inc. | 1 | $15.89 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.